Chemotherapy and Radiotherapy: Finance

Department of Health and Social Care written question – answered on 26th October 2021.

Alert me about debates like this

Photo of Maria Caulfield Maria Caulfield The Parliamentary Under-Secretary for Health and Social Care

The differential level of spending between different services and treatments is a feature of cost and volume. Levels of spending on chemotherapy is due to greater activity, drug, staff, equipment and facility costs.

However, significant investment has been made in radiotherapy, including £32 million to replace 17 Linear Accelerators aged over 10 years by the end of March 2022. Progress ontinues to be made in the range and availability of innovative radiotherapy, where the evidence base supports it through NHS England and NHS Improvement’s clinical commissioning policy process.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.